188 related articles for article (PubMed ID: 23363813)
1. The immune signature of CD8(+)CCR7(+) T cells in the peripheral circulation associates with disease recurrence in patients with HNSCC.
Czystowska M; Gooding W; Szczepanski MJ; Lopez-Abaitero A; Ferris RL; Johnson JT; Whiteside TL
Clin Cancer Res; 2013 Feb; 19(4):889-99. PubMed ID: 23363813
[TBL] [Abstract][Full Text] [Related]
2. Chemokine C receptor 7 expression and protection of circulating CD8+ T lymphocytes from apoptosis.
Kim JW; Ferris RL; Whiteside TL
Clin Cancer Res; 2005 Nov; 11(21):7901-10. PubMed ID: 16278415
[TBL] [Abstract][Full Text] [Related]
3. Effector CD8+CD45RO-CD27-T cells have signalling defects in patients with squamous cell carcinoma of the head and neck.
Kuss I; Donnenberg AD; Gooding W; Whiteside TL
Br J Cancer; 2003 Jan; 88(2):223-30. PubMed ID: 12610507
[TBL] [Abstract][Full Text] [Related]
4. Rapid turnover of the CD8(+)CD28(-) T-cell subset of effector cells in the circulation of patients with head and neck cancer.
Tsukishiro T; Donnenberg AD; Whiteside TL
Cancer Immunol Immunother; 2003 Oct; 52(10):599-607. PubMed ID: 12827303
[TBL] [Abstract][Full Text] [Related]
5. Spontaneous apoptosis of circulating T lymphocytes in patients with head and neck cancer and its clinical importance.
Hoffmann TK; Dworacki G; Tsukihiro T; Meidenbauer N; Gooding W; Johnson JT; Whiteside TL
Clin Cancer Res; 2002 Aug; 8(8):2553-62. PubMed ID: 12171883
[TBL] [Abstract][Full Text] [Related]
6. Expression of pro- and antiapoptotic proteins in circulating CD8+ T cells of patients with squamous cell carcinoma of the head and neck.
Kim JW; Tsukishiro T; Johnson JT; Whiteside TL
Clin Cancer Res; 2004 Aug; 10(15):5101-10. PubMed ID: 15297413
[TBL] [Abstract][Full Text] [Related]
7. Skewed distribution of IL-7 receptor-α-expressing effector memory CD8+ T cells with distinct functional characteristics in oral squamous cell carcinoma.
Lee JJ; Yeh CY; Jung CJ; Chen CW; Du MK; Yu HM; Yang CJ; Lin HY; Sun A; Ko JY; Cheng SJ; Chang YL; Chia JS
PLoS One; 2014; 9(1):e85521. PubMed ID: 24465587
[TBL] [Abstract][Full Text] [Related]
8. Cell surface markers for T and B lymphocytes activation and adhesion as putative prognostic biomarkers for head and neck squamous cell carcinoma.
Andrade MC; Ferreira SB; Gonçalves LC; De-Paula AM; de Faria ES; Teixeira-Carvalho A; Martins-Filho OA
Hum Immunol; 2013 Dec; 74(12):1563-74. PubMed ID: 23994583
[TBL] [Abstract][Full Text] [Related]
9. Alterations in the T-cell receptor variable beta gene-restricted profile of CD8+ T lymphocytes in the peripheral circulation of patients with squamous cell carcinoma of the head and neck.
Albers AE; Visus C; Tsukishiro T; Ferris RL; Gooding W; Whiteside TL; De Leo AB
Clin Cancer Res; 2006 Apr; 12(8):2394-403. PubMed ID: 16638844
[TBL] [Abstract][Full Text] [Related]
10. Loss of CD31 receptor in CD4+ and CD8+ T-cell subsets in children with primary hypertension is associated with hypertension severity and hypertensive target organ damage.
Gackowska L; Michałkiewicz J; Niemirska A; Helmin-Basa A; Kłosowski M; Kubiszewska I; Obrycki Ł; Szalecki M; Wierzbicka A; Kułaga Z; Wiese M; Litwin M
J Hypertens; 2018 Nov; 36(11):2148-2156. PubMed ID: 29965884
[TBL] [Abstract][Full Text] [Related]
11. Spontaneous apoptosis of tumor-specific tetramer+ CD8+ T lymphocytes in the peripheral circulation of patients with head and neck cancer.
Albers AE; Schaefer C; Visus C; Gooding W; DeLeo AB; Whiteside TL
Head Neck; 2009 Jun; 31(6):773-81. PubMed ID: 19296526
[TBL] [Abstract][Full Text] [Related]
12. Characteristics of CD4+CD25+ regulatory T cells in the peripheral circulation of patients with head and neck cancer.
Schaefer C; Kim GG; Albers A; Hoermann K; Myers EN; Whiteside TL
Br J Cancer; 2005 Mar; 92(5):913-20. PubMed ID: 15714205
[TBL] [Abstract][Full Text] [Related]
13. Imbalance in absolute counts of T lymphocyte subsets in patients with head and neck cancer and its relation to disease.
Kuss I; Hathaway B; Ferris RL; Gooding W; Whiteside TL
Adv Otorhinolaryngol; 2005; 62():161-72. PubMed ID: 15608426
[TBL] [Abstract][Full Text] [Related]
14. Tumor-derived microvesicles in sera of patients with head and neck cancer and their role in tumor progression.
Bergmann C; Strauss L; Wieckowski E; Czystowska M; Albers A; Wang Y; Zeidler R; Lang S; Whiteside TL
Head Neck; 2009 Mar; 31(3):371-80. PubMed ID: 19073006
[TBL] [Abstract][Full Text] [Related]
15. Decreased absolute counts of T lymphocyte subsets and their relation to disease in squamous cell carcinoma of the head and neck.
Kuss I; Hathaway B; Ferris RL; Gooding W; Whiteside TL
Clin Cancer Res; 2004 Jun; 10(11):3755-62. PubMed ID: 15173082
[TBL] [Abstract][Full Text] [Related]
16. Comparative analysis of naïve and memory CD4+ and CD8+ T-cell subsets in bone marrow and G-CSF-mobilized peripheral blood stem cell allografts: impact of donor characteristics.
Yakoub-Agha I; Saule P; Depil S; Grutzmacher C; Boulanger F; Magro L; Jouet JP; Dessaint JP; Labalette M
Exp Hematol; 2007 Jun; 35(6):861-71. PubMed ID: 17533040
[TBL] [Abstract][Full Text] [Related]
17. Blockade of adenosine A2A receptor enhances CD8
Ma SR; Deng WW; Liu JF; Mao L; Yu GT; Bu LL; Kulkarni AB; Zhang WF; Sun ZJ
Mol Cancer; 2017 Jun; 16(1):99. PubMed ID: 28592285
[TBL] [Abstract][Full Text] [Related]
18. Relationships between regulatory T cells and CD8+ effector populations in patients with squamous cell carcinoma of the head and neck.
Chikamatsu K; Sakakura K; Whiteside TL; Furuya N
Head Neck; 2007 Feb; 29(2):120-7. PubMed ID: 17103408
[TBL] [Abstract][Full Text] [Related]
19. Characterization of tumor-associated T-lymphocyte subsets and immune checkpoint molecules in head and neck squamous cell carcinoma.
Lechner A; Schlößer H; Rothschild SI; Thelen M; Reuter S; Zentis P; Shimabukuro-Vornhagen A; Theurich S; Wennhold K; Garcia-Marquez M; Tharun L; Quaas A; Schauss A; Isensee J; Hucho T; Huebbers C; von Bergwelt-Baildon M; Beutner D
Oncotarget; 2017 Jul; 8(27):44418-44433. PubMed ID: 28574843
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of peripheral CD8+CD28+ and CD8+CD28- T cells in advanced non-small cell lung cancer patients treated with chemo(radio)therapy.
Liu C; Jing W; An N; Li A; Yan W; Zhu H; Yu J
J Transl Med; 2019 Oct; 17(1):344. PubMed ID: 31623615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]